Aprecia’s 3DP technology platforms deliver technical and operational advantages for biotech companies seeking rapid, flexible, and individualized oral drug delivery solutions. Additive manufacturing (AM) is proven, scalable, and regulatory-accepted, positioning it as a strategic asset for next-generation therapies. Rethinking Tablet Manufacturing: The Power of Additive Manufacturing Traditional tablet manufacturing relies on fixed, bulk processes that… Continue reading Additive Manufacturing for Oral Drug Delivery
Tag: pharmaceutical manufacturing
Resilience Through Innovation: Aprecia’s Role in Strengthening the U.S. Drug Supply Chain
As the industry grapples with tariff pressures and the need to reduce reliance on global supply chains, Aprecia’s pioneering use of 3D printing enables scalable, distributed manufacturing, making domestic production not only feasible but sustainable. PHARMA MATTERS Q&A, October 23, 2025 – With supply chain headaches and a growing demand for personalized medicine, drug makers… Continue reading Resilience Through Innovation: Aprecia’s Role in Strengthening the U.S. Drug Supply Chain
Aprecia and Apprentice.io Partner to Scale Pharmaceutical 3D Printing Manufacturing
Aprecia will use Apprentice.io’s AI-powered platform to scale its innovative technology for drug delivery solutions JERSEY CITY, NJ, September 9, 2025 – Apprentice.io, the creator of the first AI-powered manufacturing platform for life sciences, today announced a strategic partnership with Aprecia, the industry leader in pharmaceutical three-dimensional printing (3DP). This collaboration marks a significant step… Continue reading Aprecia and Apprentice.io Partner to Scale Pharmaceutical 3D Printing Manufacturing